3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
24
Gastrointestinal
3
Breast
2
Other solid neoplasm
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Conditions
Motor Activity
22
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Lymphoma
11
Lymphoma, Follicular
5
Leukemia
5
Leukemia, Lymphocytic, Chronic, B-Cell
4
Breast Neoplasms
4
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Obesity
2
Neoplasms
2
Hodgkin Disease
2
Fatigue
2
Cardiotoxicity
2
Waldenstrom Macroglobulinemia
1
Ventricular Dysfunction, Left
1
Urogenital Neoplasms
1
Thyroid Neoplasms
1
Sarcopenia
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Parasomnias
1
Overweight
1
Ovarian Neoplasms
1
Non-alcoholic Fatty Liver Disease
1
Neoplasms, Plasma Cell
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Interventions
pembrolizumab
6
Magnetic Resonance Spectroscopy
5
Gemcitabine
4
Specimen Handling
3
Nivolumab
3
Drug Therapy
3
epacadostat
2
Therapeutics
2
Taxes
2
Sirolimus
2
Paclitaxel
2
Doxorubicin
2
Blood Specimen Collection
2
Biopsy
2
Azacitidine
2
vandetanib
1
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
toripalimab
1
temsirolimus
1
tanespimycin
1
spartalizumab
1
sargramostim
1
sapanisertib
1
romidepsin
1
relatlimab
1
pertuzumab
1
pegfilgrastim
1
palbociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Exercise
×
Lymphoid
×
Clear all
NCT05509751
2026-04-28
SOAR
University of Toronto
Phase NA
Active not recruiting
60 enrolled